Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[Circulating microRNA-92a in patients with ST-segment elevation myocardial infarction].

Wang H, Lin YZ, Lu HM, Zhou Y, Luo C, Lu SH, Zhao L, Liu F.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Dec;23(12):718-22. Chinese.

2.

Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction).

Antonsen L, Jensen LO, Thayssen P, Christiansen EH, Junker A, Tilsted HH, Terkelsen CJ, Kaltoft A, Maeng M, Hansen KN, Ravkilde J, Lassen JF, Madsen M, Sørensen HT, Thuesen L.

Am J Cardiol. 2011 Nov 15;108(10):1395-400. doi: 10.1016/j.amjcard.2011.06.062. Epub 2011 Sep 3.

PMID:
21890087
3.

Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.

Seo SM, Kim S, Chang K, Min J, Kim TH, Koh YS, Park HJ, Shin WS, Lee JM, Kim PJ, Chung WS, Seung KB.

Coron Artery Dis. 2011;22(6):405-10. doi: 10.1097/MCA.0b013e3283487dac.

PMID:
21701385
4.

[Evaluation of circulating microRNA-92a for endothelial damage induced by percutaneous coronary intervention].

Wang H, Wang L, Liu L, Lin YZ, Li YQ, Lu HM, Gong GP.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Dec;24(12):721-4. Chinese.

5.

Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris.

Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A.

Scand J Clin Lab Invest. 2011 Jul;71(4):322-9. doi: 10.3109/00365513.2011.565367. Epub 2011 Apr 4.

PMID:
21463159
6.

Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.

Zhang Q, Zhang RY, Qiu JP, Zhang JF, Wang XL, Jiang L, Liao ML, Zhang JS, Hu J, Yang ZK, Shen WF.

Chin Med J (Engl). 2008 Mar 20;121(6):485-91.

PMID:
18364130
7.

[The influence of statin therapy on circulating microRNA-92a expression in patients with coronary heart disease].

Wang H, Lu HM, Yang WH, Luo C, Lu SH, Zhou Y, Lin YZ.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Apr;24(4):215-8. Chinese.

8.

Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".

Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV; Herzinfarktverbund Essen.

Herz. 2008 Mar;33(2):136-42. doi: 10.1007/s00059-008-3102-8.

PMID:
18344033
9.

Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.

Hirsch A, Verouden NJ, Koch KT, Baan J Jr, Henriques JP, Piek JJ, Rohling WJ, van der Schaaf RJ, Tijssen JG, Vis MM, de Winter RJ.

Am J Cardiol. 2009 Aug 1;104(3):333-7. doi: 10.1016/j.amjcard.2009.03.052. Epub 2009 Jun 6.

PMID:
19616663
10.

[Changes of circulating endothelial progenitor cells in patients with coronary heart diseases before and after percutaneous coronary intervention].

Luo YS, Qian JY, Zhang L, Ma JY, Huang D, Fan B, Ge JB.

Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Feb;38(2):126-30. Chinese.

PMID:
20398557
11.

Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes.

Dudek D, Mielecki W, Wizimirski M, Rakowski T, Dziewierz A, Sorysz D, Tomala M, Zorkun C, Zmudka K, Dubiel JS.

Kardiol Pol. 2004 Sep;61(9):232-41; discussion 242. English, Polish.

PMID:
15531935
12.

[Hospital mortality trend analysis of patients with ST elevation myocardial infarction in the Belgrade area coronary care units].

Vasiljević Z, Stojanović B, Kocev N, Stefanović B, Mrdović I, Ostojić M, Krotin M, Putniković B, Dimković S, Despotović N.

Srp Arh Celok Lek. 2008 May;136 Suppl 2:84-96. Serbian.

13.
14.

[Efficacy and outcome of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction due to saphenous vein graft occlusion].

Ergelen M, Uyarel H, Gül M, Türer A, Yıldırım E, Bozbay M, Demirci D, Ersan D, Türkkan C, Uluganyan M, Tezel T.

Turk Kardiyol Dern Ars. 2010 Dec;38(8):531-6. Turkish.

16.

Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.

Dryja T, Kornacewicz-Jach Z, Goracy J, Przybycień K, Jodko L, Skowronek A, Kurowski M, Zinka E.

Kardiol Pol. 2006 Jun;64(6):591-9; discussion 600-1.

PMID:
16810577
17.

[Increased postprocedural neutrophil count is an independent predictive factor of poor prognosis in acute ST elevation myocardial infarction patients treated with percutaneous coronary intervention].

He R, Yang ZH, Li HY, Guo LJ, Zhang FC, Niu J, Zhang YZ, Wang GS, Gao W.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Jan;37(1):44-8. Chinese.

PMID:
19671351
18.
19.

Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.

Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E; TIMI Study Group.

Am Heart J. 2008 Jan;155(1):133-9. Epub 2007 Nov 19.

PMID:
18082504
20.

[Single lead ST-segment resolution in acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: prognostic impact and associated factors].

Zhang DP, Yang XC, Wang LF, Ge YG, Wang HS, Li WM, Xu L, Ni ZH, Luan YY, Xue YL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Mar;35(3):227-32. Chinese.

PMID:
17582286

Supplemental Content

Support Center